Literature DB >> 26782214

Direct Evidence of the Link Between Energetic Metabolism and Proliferation Capacity of Cancer Cells In Vitro.

Géraldine De Preter1, Pierre Danhier1, Paolo E Porporato2, Valéry L Payen2, Bénédicte F Jordan1, Pierre Sonveaux2, Bernard Gallez3.   

Abstract

The aim of the study was to assess the link between the metabolic profile and the proliferation capacity of a range of human and murine cancer cell lines. First, the combination of mitochondrial respiration and glycolytic efficiency measurements allowed the determination of different metabolic profiles among the cell lines, ranging from a mostly oxidative to a mostly glycolytic phenotype. Second, the study revealed that cell proliferation, evaluated by DNA synthesis measurements, was statistically correlated to glycolytic efficiency. This indicated that glycolysis is the key energetic pathway linked to cell proliferation rate. Third, to validate this hypothesis and exclude non-metabolic factors, mitochondria-depleted were compared to wild-type cancer cells, and the data showed that enhanced glycolysis observed in mitochondria-depleted cells is also associated with an increase in proliferation capacity.

Entities:  

Keywords:  Aerobic glycolysis; Cancer metabolism; Electron paramagnetic resonance; Oxidative phosphorylation; Proliferation

Mesh:

Year:  2016        PMID: 26782214     DOI: 10.1007/978-1-4939-3023-4_26

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Evaluation of Syrosingopine, an MCT Inhibitor, as Potential Modulator of Tumor Metabolism and Extracellular Acidification.

Authors:  Chloe Buyse; Nicolas Joudiou; Aude Warscotte; Elena Richiardone; Lionel Mignion; Cyril Corbet; Bernard Gallez
Journal:  Metabolites       Date:  2022-06-17

2.  Endogenous electromagnetic forces emissions during cell respiration as additional factor in cancer origin.

Authors:  Abraham A Embi
Journal:  Cancer Cell Int       Date:  2016-07-28       Impact factor: 5.722

3.  Multimodality Imaging Identifies Distinct Metabolic Profiles In Vitro and In Vivo.

Authors:  Marie-Aline Neveu; Géraldine De Preter; Valérie Marchand; Anne Bol; Jeffery R Brender; Keita Saito; Shun Kishimoto; Paolo E Porporato; Pierre Sonveaux; Vincent Grégoire; Olivier Feron; Bénédicte F Jordan; Murali C Krishna; Bernard Gallez
Journal:  Neoplasia       Date:  2016-11-24       Impact factor: 5.715

4.  Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.

Authors:  Marie-Aline Neveu; Géraldine De Preter; Nicolas Joudiou; Anne Bol; Jeffery R Brender; Keita Saito; Shun Kishimoto; Vincent Grégoire; Bénédicte F Jordan; Murali C Krishna; Olivier Feron; Bernard Gallez
Journal:  Oncotarget       Date:  2016-12-06

5.  Metformin and propranolol combination prevents cancer progression and metastasis in different breast cancer models.

Authors:  María Rico; María Baglioni; Maryna Bondarenko; Nahuel Cesatti Laluce; Viviana Rozados; Nicolas André; Manon Carré; O Graciela Scharovsky; Mauricio Menacho Márquez
Journal:  Oncotarget       Date:  2017-01-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.